Presence of heart failure is associated with a poor prognosis in patients with coronavirus disease 2019 (COVID-19). The aim of the present study was to examine whether first-phase ejection fraction (EF1), the ejection fraction measured in early systole up to the time of peak aortic velocity, a sensitive measure of preclinical heart failure, is associated with survival in patients hospitalized with COVID-19. A retrospective outcome study was performed in patients hospitalized with COVID-19 who underwent echocardiography (n=380) at the West Branch of the Union Hospital, Wuhan, China and in patients admitted to King’s Health Partners in South London, United Kingdom. Association of EF1 with survival was performed using Cox proportional hazards regression. EF1 was compared in patients with COVID-19 and in historical controls with similar comorbidities (n=266) who had undergone echocardiography before the COVID-19 pandemic. In patients with COVID-19, EF1 was a strong predictor of survival in each patient group (Wuhan and London). In the combined group, EF1 was a stronger predictor of survival than other clinical, laboratory, and echocardiographic characteristics including age, comorbidities, and biochemical markers. A cutoff value of 25% for EF1 gave a hazard ratio of 5.23 ([95% CI, 2.85–9.60]; P<0.001) unadjusted and 4.83 ([95% CI, 2.35–9.95], P<0.001) when adjusted for demographics, comorbidities, hs-cTnI (high-sensitive cardiac troponin), and CRP (C-reactive protein). EF1 was similar in patients with and without COVID-19 (23.2±7.3 versus 22.0±7.6%, P=0.092, adjusted for prevalence of risk factors and comorbidities). Impaired EF1 is strongly associated with mortality in COVID-19 and probably reflects preexisting, preclinical heart failure.
1 September 2017 in Journal of the American Society of Echocardiography
The use of transcatheter aortic valve replacement (TAVR) is increasing worldwide. We present our 6-year experience using three-dimensional (3D) transesophageal echocardiography (TEE) and investigate whether different sizing methods of the aortic annulus lead to different prosthesis size that may impact outcome. We investigated 262 patients who underwent TAVR and had 3D TEE data sets of the aortic annulus. We have used the area-derived diameter (Darea = 2(area/π)) and the circumference-derived diameter (Dcirc = Circumference/π) to size the prosthesis in separate populations in different time periods. The Dcirc method is correlated with lower incidence of paravalvular aortic regurgitation (PVAR; odds ratio = 0.44, 95% confidence interval, 0.23-0.85; P = .015). Other factors associated with PVAR were the cover index, area-mismatch index, and circumference-mismatch index. Retrospectively, for the purposes of the study, we used the Edwards-Sapien 3 Valve 3D sizing guide in all patients, to predict the hypothetical valve size with each method. In the whole population, the calculated Dcirc was higher in all cases (Dcirc = 23.4 ± 2.3 mm vs Darea = 22.9 ± 2.3 mm; P < .001). The two methods had good agreement in predicting the valve size (kappa = 0.600). In total, 192 (73.3%) patients were assigned for the same prosthesis size, whereas 70 (26.7%) would be eligible for a different size, of which 44 (16.7%) would definitely have had a different valve implanted. Using the aortic annulus area or circumference to calculate the annular diameter provides different values. Comparing the two methods, a different prosthesis size could have been implanted in 26.7% of patients. In our series the use of circumference-derived diameter resulted in lower incidence of PVAR. The findings of this study may be independent of the imaging modality and may therefore also apply to computed tomography-based aortic annulus measurements, but this needs to be further investigated.
7 January 2022 in The International Journal of Cardiovascular Imaging
A 20-year-old man with known bicuspid aortic valve, and aortic coarctation repair in childhood presented with 4 weeks of vomiting, diarrhoea, low grade fever, productive cough, and progressive breathlessness. Auscultation revealed fine crackles bilaterally and a loud systolic murmur at the base of the heart. Inflammatory markers and troponin were elevated (troponin T 388 ng/L; cut-off for normal <14 ng/L). Initial ECG showed only sinus tachycardia. Chest X-ray (Panel A) showed bilateral airspace infiltrates suspicious of COVID pneumonitis. Shortly after admission, he deteriorated, with rising oxygen requirements and haemoptysis. A repeat ECG showed first-degree atrioventricular (AV) block with widespread ischaemia (Panel B).
18 March 2025 in European Heart Journal - Digital Health
Aims: Aortic stenosis (AS) is a condition marked by high morbidity and mortality in severe, symptomatic cases without intervention via transcatheter aortic valve implantation (TAVI) or surgical aortic valve replacement (SAVR). Racial and ethnic disparities in access to these treatments have been documented, particularly in North America, where socioeconomic factors such as health insurance confound analyses. This study evaluates disparities in AS management across racial and ethnic groups, accounting for socioeconomic deprivation, using an artificial intelligence (AI) framework. Methods and results: We conducted a retrospective cohort study using a natural language processing pipeline to analyse both structured and unstructured data from > 1 million patients at a London hospital. Key variables included age, sex, self-reported race and ethnicity, AS severity, and socioeconomic status. The primary outcomes were rates of valvular intervention and all-cause mortality. Among 6967 patients with AS, Black patients were younger, more symptomatic, and more comorbid than White patients. Black patients with objective evidence of AS on echocardiography were less likely to receive a clinical diagnosis than White patients. In severe AS, TAVI and SAVR procedures were performed at lower rates among Black patients than among White patients, with a longer time to SAVR. In multivariate analysis of severe AS, controlling for socioeconomic status, Black patients experienced higher mortality (hazard ratio = 1.42, 95% confidence interval = 1.05–1.92, P = 0.02). Conclusion: An AI framework characterizes racial and ethnic disparities in AS management, which persist in a universal healthcare system, highlighting targets for future healthcare interventions.
Aims Patients with de novo chest pain are usually investigated non-invasively. The new UK-National Institute for Health and Care Excellence (NICE) guidelines recommend CT coronary angiography (CTCA) for all patients, while European Society of Cardiology (ESC) recommends functional tests. We sought to compare the clinical utility and perform a cost analysis of these recommendations in two UK centres with different primary investigative strategies. Methods—results We compared two groups of patients, group A (n=667) and group B (n=654), with new onset chest pain in two neighbouring National Health Service hospitals, each primarily following either ESC (group A) or NICE (group B) guidance. We assessed the clinical utility of each strategy, including progression to invasive coronary angiography (ICA) and revascularisation. We present a retrospective cost analysis in the context of UK tariff for stress echo (£176), CTCA (£220) and ICA (£1001). Finally, we sought to identify predictors of revascularisation in the whole population. Baseline characteristics in both groups were similar. The progression to ICA was comparable (9.9% vs 12.0%, p=0.377), with similar requirement for revascularisation (4.0% vs 5.0%.; p=0.532). The average cost of investigations per investigated patient was lower in group A (£279.66 vs £325.77), saving £46.11 per patient. The ESC recommended risk score (RS) was found to be the only predictor of revascularisation (OR 1.05, 95% CI 1.04 to 1.06; p<0.001). Conclusion Both NICE and ESC-proposed strategies led to similar rates of ICA and need for revascularisation in discrete, but similar groups of patients. The SE-first approach had a lower overall cost by £46.11 per patient, and the ESC RS was the only variable correlated to revascularisation.